Dr. Maria T. Millan, President and CEO of CIRM, presenting the President's Report CIRM’s Board received an update on our clinical portfolio, which now includes 60 trials across multiple diseases. The President’s Report highlights 15 trials, our Cure Sickle Cell Initiative with the NIH, and our educational programs. We want to share key updates showing … Continue reading CIRM Board Meeting Highlights: Clinical Trials and CIRM’s President’s Report
Maria T. Millan
CIRM applauds FDA crackdown on stem cell clinics that “peddle unapproved treatments.”
CIRM is commending the US Food and Drug Administration (FDA) for its action against two stem cell clinics offering unapproved therapies. On Wednesday, the FDA filed two complaints in federal court seeking a permanent injunction against California Stem Cell Treatment Center Inc. and US Stem Cell Clinic LLC. of Sunrise, Florida. The FDA says the … Continue reading CIRM applauds FDA crackdown on stem cell clinics that “peddle unapproved treatments.”